Hypera Pharma (HYPE3Q) Cotización

3 Solid Tweets After Hours Today between the CRO, Calvin Frye and one with an Investor »» 

$HADV More progress with our SoEquity project. A portion of the capital raised by SoEquity will be provided to Health Advance for our progress, without common share dilution for that purpose.

Well lets just pray we don't see a fresh replay when we soon get approval.

" buffet..oil wells..amazon..somebodies green front yard...........oh wait------a handful of geese in a pond----------( fwiw ...geese dont care if the water has algae -------and golf courses HATE geese )-------------what a pile o nonsense...........

IT SHOULD GET VERY INTERESTING ALL THE WAY TO END OF MARCH YEARLY REPORT DUE.

That's the spirit, cap! Johnson got in, it has to be better than Jefferies! Now, let's see if the Republicans can stick together and get Trump's agenda done before the 2026 elections.

More free shares for the superstar 💩 CEO!!!

Common Stock 01/02/2025 A(1) 1,000,000 A $0 1,001,098(2) D
Common Stock 01/02/2025 A(3) 2,286 A $0 1,003,384 D
Common Stock 01/02/2025 A(4) 200,577 A $0 1,203,961 D
https://ih.advfn.com/stock-market/NASD

pwm..............................a/h

I like real honey in my lemonade squeezed fresh. Not bad with tequila either. Time for the beach.
Last year was good to me, and thus far 2025 is shaping up nicely. Enjoy your weekend as well.

Yes, getting to product phase is incredibly complex

Not at all easy for a junior to accomplsh......which is why an Australian company just bought these guys.....
At least now they're better funded to advance.
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?

Hey Hey! OKWIFE in the house! Welcome! Volume b4 price!

plus the company is way overdue to lay out what is happening behind the scenes. i think otiko was waiting for a fresh new year to let it rip..we will know soon enough

FNMA 4.47 up 29.8% for the day, ended at its high. gained $1.03...wow has not been this high since 2/2017. when will it break 3/2014 level at 6.35?🚀

Im still 12.00 down at 137 average. Not so exciting

Mike Johnson Speaker of the House vote live updates: Johnson takes oath of office, swears in reps
By Josh Christenson, Diana Glebova, David Spector and Kaydi Pelletier Updated Jan. 3, 2025, 4:44 p.m. ET

Speaker of the House Mike Johnson was elected Speaker of the House for the

You have not provided any evidence that Endovo Sofpulse and the Zomedica Assisi Loop are significantly different from Actipatch. All you've said is look in some attachments.

Even after I provided you the answer (strength can be significantly manipulated by the area and shape of the

Why is nothing getting done he promised? Looks like a quitter to me.

Imo,a couple of more news releases will take place very shortly,then a huge capital raise,which is needed before Q2,then a string of news releases that will propel the stock price well over $4.00 US,then they will announce they are making an application for the NASDAQ.
Should be on it by

Sweet! Tesla's got it all! As we approach Jan 20, this will fly again to new highs, but man that was a vicious correction!

Until APRU is cleaned up, has an……

ACTIVE status in Illinois, and the beneficial ownership is clear, he could give Ross all the money in the world but the Lena purchase cannot occur.

Ross has obviously been patient but how long will that last?

The fins e

CRIS 3.80 add looking good

Nail the f*ck

https://x.com/MacFarlaneNews/status/1875305357431771628?s=19

marcis
Re: Shareing is winning post# 38165

Friday, January 03, 2025 1:13:16 PM

Post# 38166 of 38211
BS
How do you have twice the amount from 16 to 13/
Read the post again ivy leaguer almost twice, at what price did I purchase the shares tha

swin...................https://stockcharts.com/h-sc/ui?s=swin&p=W&b=5&g=0&id=p86431144783

EX,

Are these measures adopted in the combo trial revolutionary and disruptive? There is no other trial on clinicaltrials.gov that has ever adopted outcome measures like these. These measures are only applicable under the condition that massive and sustainable t-cell infiltration into